Venture Capital Investors
InfectoPharm
InfectoPharm provides venture capital investment to companies focused on high-impact, technology-driven solutions.
Venture Investor Overview
Venture Investor
InfectoPharm
Investor Type
Venture Capital
Industry Focus
Biopharmaceutical
Contact Information
Title
Chief Executive Officer
Mailing Address
Von-Humboldt-Str. 1
Heppenheim, 64646
Germany
Background Information
Overview
InfectoPharm is a medium-sized family-run business that specializes in the development of medications for children. As the leading pediatric pharmaceutical company in Germany, all of our products deliver the added value that patients, physicians and pharmacists have come to expect from us over the past 35 years. InfectoPharm successfully develops and adapts medically proven active ingredients to meet the distinctive needs of children. This promotes therapy adherence, avoids unwanted therapeutic off-label use and helps young patients to recover faster: InfectoPharm's unique products are recommended in medical guidelines and are trusted for use in standard therapies. They clearly differ from existing ones in terms of their galenics, potency, dosage or taste.
Last Transaction
2/14/2025
Transaction History
Our records indicate that InfectoPharm invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.
2/14/2025
Undisclosed
Unknown
Investor Contacts
Chief Executive Officer
Philipp Zöller
Funds
No fund closings have been recorded for this company.
Portfolio Companies
InfectoPharm has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.
Browse more venture capital investors:
Infarm | Inference Partners
Share this article
About Our Venture Capital Investor Database
This VC firm profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs
